Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Kuwait

Steady Growth Expected In Kuwaiti Drug Sector

May 2006 | Five Year Forecasts

The Kuwaiti pharmaceutical market can be expected to continue to grow steadily, if moderately, in the short term. Offsetting this expected growth is the government's cost-containment policy, which should see it focus more on generic provision. This could restrict the marketplace for branded products. The market is likely to reach about US$438.7mn at consumer prices by 2010, equal to US$175.5 per

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Counterfeiters Target Middle East

Companies / Kuwait The Middle East is becoming an attractive destination for counterfeiters, according to delegates at the Regional Anti-Counterfeiting Forum, which was recently held in Amman, Jordan. The head of
December 2006
Dar Al Dawa Beats Expectations

Companies / Kuwait Jordanian drugmaker Dar Al Dawa (DAD) has announced a 19.2% growth in sales for the first three quarters of the year to JOD28.36 (US$40.02mn). On the back of this strong performance full year sales are...
November 2006
Hikma Announces Lower Sales Forecast

Companies / Kuwait Jordanian drugmaker Hikma has announced that it expects lower generics sales for 2006, due to the weaker than expected performance of its new products. Like most generic firms, Hikma is feeling the effects...
October 2006
Government Refutes Privatisation Claims

Companies / Kuwait Jordan's Health Minister has denied claims that the government is planning to fully privatise the health sector, citing the fact that three public hospitals have recently been constructed. Building work...
October 2006
Hikma Reports Strong First Half

Companies / Kuwait Jordan-based generic drugmaker Hikma Pharmaceuticals has unveilled a 9.5% increase in profits for H106, driven by strong revenue growth for is branded and injectable drug businesses. Profits reached...
September 2006
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS